Litigation

Litigation Expert Justin VandenBout Enhances Norton Rose Fulbright’s Houston Team with His Diverse Practice Experience

by

Houston, TX – Norton Rose Fulbright, a prominent global law firm, bolstered its litigation force in Houston with the recent addition of Justin VandenBout as a partner in the firm’s Products, Pharma, Medical and Mass Tort practice team. VandenBout, previously with Chamberlain Hrdlicka, is recognized for his expertise in managing a comprehensive range of litigations across the United States. VandenBout brings a rich portfolio of experience in various areas including commercial and product liability litigation, insurance coverage, and mass torts. His expertise extends to environmental litigation, class actions, disaster response, catastrophic injury, intellectual property, construction … Read more

Navigating the Wave of Paraquat Litigation: Emerging Developments and Key Trials Shaping the Future of Settlements

by

WASHINGTON — Litigation concerning the herbicide Paraquat, linked to Parkinson’s disease, continues to evolve across the United States, where attorneys are busy handling lawsuits on behalf of individuals who have been affected. This chemical, used extensively in agriculture, has come under scrutiny for its potential health risks, particularly its connection to Parkinson’s disease in those exposed to it. Parkinson’s disease, a neurological disorder marked by tremors, stiffness, and other movement difficulties, is at the center of these lawsuits. Plaintiff’s attorneys argue that prolonged exposure to Paraquat significantly increases the risk of developing this life-altering condition. … Read more

Flint Cooper’s Alex Parker Takes on Key Role in Opioid Crisis Legal Battle, Joins Leadership Team in Suboxone Litigation

by

Flint, MI – Alex Parker, a seasoned attorney at Flint Cooper, has been appointed to the Leadership Development Committee in the multifaceted Suboxone multidistrict litigation. This prominent role underscores Parker’s reputation in the legal community and highlights the significant responsibilities and influence that such positions entail. Parker’s appointment is a strategic move in the litigation that involves numerous cases related to the opioid treatment drug, Suboxone. These cases have been consolidated due to their shared legal questions concerning the drug’s marketing and safety practices. By taking on this pivotal role, Parker not only represents Flint … Read more

Recent Developments in Zantac Litigation: Key Updates for Affected Consumers

by

Washington — Thousands of lawsuits have been filed against the manufacturers of Zantac and its generic forms, alleging that the popular heartburn medication may cause cancer. The legal battles represent a significant chapter in pharmaceutical litigation, underscoring ongoing concerns regarding drug safety and consumer protection. The controversy began after the U.S. Food and Drug Administration (FDA) warned in 2019 that Zantac (ranitidine) might contain a probable human carcinogen called N-nitrosodimethylamine (NDMA). Following these findings, the FDA requested the removal of all ranitidine products from the market in April 2020, leading to widespread recall and discontinuation … Read more